T1	DISO 1167 1186	efectos indeseables
#1	AnnotatorNotes T1	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T2	PROC 93 119	cirugía proximal de húmero
T3	ANAT 113 119	húmero
#2	AnnotatorNotes T3	C0020164; Bone structure of humerus; Body Part, Organ, or Organ Component | C1279075; Entire humerus; Body Part, Organ, or Organ Component
T4	PROC 135 155	Comparar la eficacia
#3	AnnotatorNotes T4	C1707887; Efficacy Study; Research Activity
T5	DISO 183 199	efectos adversos
#4	AnnotatorNotes T5	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T6	PROC 209 253	bloqueo interesternocleidomastoideo continuo
T7	PROC 260 288	pauta analgésica intravenosa
T8	PROC 294 320	cirugía proximal de húmero
T9	ANAT 314 320	húmero
#5	AnnotatorNotes T9	C0020164; Bone structure of humerus; Body Part, Organ, or Organ Component | C1279075; Entire humerus; Body Part, Organ, or Organ Component
T10	PROC 343 390	Estudio prospectivo descriptivo no aleatorizado
T11	PROC 404 416	intervenidos
#6	AnnotatorNotes T11	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T12	PROC 420 437	cirugía de hombro
#7	AnnotatorNotes T12	C0186321; Operative procedure on shoulder; Therapeutic or Preventive Procedure
T13	PROC 443 460	anestesia general
#8	AnnotatorNotes T13	C0002915; General Anesthesia; Therapeutic or Preventive Procedure
T14	CHEM 465 474	fentanilo
#9	AnnotatorNotes T14	C0015846; Fentanyl; Organic Chemical · Pharmacologic Substance
T15	PROC 541 576	bloqueo interesternocleidomastoideo
T16	CHEM 581 592	ropivacaína
#10	AnnotatorNotes T16	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T17	PROC 635 644	perfusión
#11	AnnotatorNotes T17	C0031001; Perfusion (procedure); Therapeutic or Preventive Procedure
T18	PROC 678 687	bolos PCA
T19	CHEM 795 804	metamizol
#12	AnnotatorNotes T19	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T20	CHEM 811 819	tramadol
#13	AnnotatorNotes T20	C0040610; tramadol; Organic Chemical · Pharmacologic Substance
T21	CHEM 830 841	ondansetrón
#14	AnnotatorNotes T21	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T22	PROC 865 874	perfusión
#15	AnnotatorNotes T22	C0031001; Perfusion (procedure); Therapeutic or Preventive Procedure
T23	CHEM 895 903	tramadol
#16	AnnotatorNotes T23	C0040610; tramadol; Organic Chemical · Pharmacologic Substance
T24	CHEM 912 923	ondansetrón
#17	AnnotatorNotes T24	C0061851; ondansetron; Organic Chemical · Pharmacologic Substance
T25	PROC 945 954	bolos PCA
T26	PROC 1020 1055	valoración del dolor postoperatorio
T27	DISO 1035 1055	dolor postoperatorio
#18	AnnotatorNotes T27	C0030201; Pain, Postoperative; Sign or Symptom
T28	PROC 1259 1294	valoración del dolor postoperatorio
T29	DISO 1274 1294	dolor postoperatorio
#19	AnnotatorNotes T29	C0030201; Pain, Postoperative; Sign or Symptom
T30	DISO 1537 1545	disfonía
#20	AnnotatorNotes T30	C1527344; Dysphonia; Mental or Behavioral Dysfunction
T31	DISO 1552 1568	ptosis palpebral
#21	AnnotatorNotes T31	C0005745; Blepharoptosis; Disease or Syndrome
T32	DISO 1576 1593	náuseas y vómitos
#22	AnnotatorNotes T32	C0027498; Nausea and vomiting; Sign or Symptom
T33	DISO 1662 1679	náuseas y vómitos
#23	AnnotatorNotes T33	C0027498; Nausea and vomiting; Sign or Symptom
T34	DISO 1699 1707	sedación
#24	AnnotatorNotes T34	C0235195; Sedated state; Finding
T35	PROC 1734 1777	PCA por catéter interesternocleidomastoideo
T36	DISO 1902 1921	efectos indeseables
#25	AnnotatorNotes T36	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T37	PROC 1875 1890	PCA intravenosa
T38	PROC 1 54	Analgesia PCA por catéter interesternocleidomastoideo
T39	PROC 62 87	analgesia PCA intravenosa
T40	ANAT 431 437	hombro
#26	AnnotatorNotes T40	C0037004; Shoulder; Body Location or Region | C1283792; Entire shoulder region; Body Location or Region
T41	PROC 492 501	analgesia
#27	AnnotatorNotes T41	C3202977; Analgesia; Therapeutic or Preventive Procedure
T42	CHEM 648 659	ropivacaína
#28	AnnotatorNotes T42	C0073571; ropivacaine; Organic Chemical · Pharmacologic Substance
T43	CHEM 878 887	metamizol
#29	AnnotatorNotes T43	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T44	DISO 1122 1127	dolor
#30	AnnotatorNotes T44	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T45	DISO 1142 1147	dolor
#31	AnnotatorNotes T45	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T46	PROC 1475 1495	analgesia de rescate
T47	ANAT 1559 1568	palpebral
#32	AnnotatorNotes T47	C0015426; Eyelid structure; Body Part, Organ, or Organ Component | C1280734; Entire eyelid; Body Part, Organ, or Organ Component
T48	PROC 1857 1866	analgesia
#33	AnnotatorNotes T48	C3202977; Analgesia; Therapeutic or Preventive Procedure
T49	DEVI 19 26	catéter
#34	AnnotatorNotes T49	C0085590; catheter device; Medical Device
T50	Route 76 87	intravenosa
#35	AnnotatorNotes T50	C1522726; Intravenous Route of Drug Administration; Functional Concept
T51	Route 277 288	intravenosa
#36	AnnotatorNotes T51	C1522726; Intravenous Route of Drug Administration; Functional Concept
T53	LIVB 394 403	pacientes
#37	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Route 475 486	intravenoso
#38	AnnotatorNotes T54	C1522726; Intravenous Route of Drug Administration; Functional Concept
T55	Time 502 517	intraoperatoria
#39	AnnotatorNotes T55	C0021891; Intraoperative Period; Temporal Concept | C0456904; Intraoperative; Temporal Concept
T56	Dose 593 609	0,5% 0,4 mL Kg-1
T58	Dose 660 668	0,2% 5mL
T59	Dose 688 692	5 mL
T60	Duration 715 725	30 minutos
T61	Dose 776 785	una dosis
T62	Dose 805 809	2 gr
T63	Dose 820 827	100 mgr
T64	Dose 842 847	4 mgr
T65	Dose 888 893	0,16%
T66	Dose 924 940	0,0016% a 1,5 mL
T67	Dose 955 959	1 mL
T68	Duration 979 989	20 minutos
T69	Date 1041 1055	postoperatorio
#40	AnnotatorNotes T69	C0032790; Postoperative Period; Temporal Concept
T70	Neg_cue 1119 1121	no
T71	LIVB 1218 1227	pacientes
#41	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T72	Date 1280 1294	postoperatorio
#42	AnnotatorNotes T72	C0032790; Postoperative Period; Temporal Concept
T73	Duration 1338 1359	las primeras 24 horas
T74	Duration 1378 1390	las 48 horas
T76	LIVB 1640 1649	pacientes
#43	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	DEVI 1742 1749	catéter
#44	AnnotatorNotes T77	C0085590; catheter device; Medical Device
T78	Route 1879 1890	intravenosa
#45	AnnotatorNotes T78	C1522726; Intravenous Route of Drug Administration; Functional Concept
T79	Duration 1926 1947	las primeras 48 horas
T81	PHYS 1069 1079	movimiento
#46	AnnotatorNotes T81	C0026649; Movement; Organism Function
T82	PHYS 1363 1373	movimiento
#47	AnnotatorNotes T82	C0026649; Movement; Organism Function
T83	PHYS 1416 1426	movimiento
#48	AnnotatorNotes T83	C0026649; Movement; Organism Function
T52	Frequency 669 672	h-1
T57	Route 678 683	bolos
#49	AnnotatorNotes T57	C1554882; Injection, intravenous, bolus; Functional Concept | C1522229; Intravenous Bolus; Functional Concept
T84	Dose 904 909	0,04%
T85	Frequency 941 944	h-1
T86	Route 945 950	bolos
#50	AnnotatorNotes T86	C1554882; Injection, intravenous, bolus; Functional Concept | C1522229; Intravenous Bolus; Functional Concept
T75	Date 1952 1966	postoperatorio
#51	AnnotatorNotes T75	C0032790; Postoperative Period; Temporal Concept
A1	Assertion T44 Negated
R1	Negation Arg1:T70 Arg2:T44	
T80	Neg_cue 375 377	no
T87	Quantifier_or_Qualifier 378 390	aleatorizado
A2	Assertion T87 Negated
R2	Negation Arg1:T80 Arg2:T87	
R3	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T87	
T88	Neg_cue 1452 1454	No
T89	CONC 1460 1471	diferencias
#52	AnnotatorNotes T89	C1705241; Delta (difference); Quantitative Concept
A3	Assertion T89 Negated
R4	Negation Arg1:T88 Arg2:T89	
R5	Used_for Arg1:T49 Arg2:T38	
R6	Has_Route_or_Mode Arg1:T39 Arg2:T50	
R7	After Arg1:T39 Arg2:T2	
R8	Location_of Arg1:T3 Arg2:T2	
R9	After Arg1:T38 Arg2:T2	
R10	Causes Arg1:T6 Arg2:T5	
R11	Causes Arg1:T7 Arg2:T5	
R12	Has_Route_or_Mode Arg1:T7 Arg2:T51	
R13	After Arg1:T6 Arg2:T8	
R14	After Arg1:T7 Arg2:T8	
R15	Experiences Arg1:T53 Arg2:T11	
R16	Experiences Arg1:T53 Arg2:T12	
R17	Location_of Arg1:T40 Arg2:T12	
R18	Experiences Arg1:T53 Arg2:T13	
R19	Before Arg1:T13 Arg2:T12	
R20	Before Arg1:T13 Arg2:T11	
R22	Has_Route_or_Mode Arg1:T14 Arg2:T54	
R23	Used_for Arg1:T14 Arg2:T41	
R24	Overlap Arg1:T41 Arg2:T55	
R25	Experiences Arg1:T53 Arg2:T41	
R26	Used_for Arg1:T16 Arg2:T15	
R27	Has_Dose_or_Strength Arg1:T16 Arg2:T56	
R28	Before Arg1:T15 Arg2:T17	
R29	Used_for Arg1:T42 Arg2:T17	
R30	Has_Dose_or_Strength Arg1:T42 Arg2:T58	
R31	Has_Frequency Arg1:T42 Arg2:T52	
R32	Used_for Arg1:T42 Arg2:T18	
R33	Has_Route_or_Mode Arg1:T42 Arg2:T57	
R34	Has_Dose_or_Strength Arg1:T42 Arg2:T59	
T90	CONC 695 711	tiempo de cierre
#53	AnnotatorNotes T90	C4068527; PCA lockout time; Temporal Concept 
R35	Has_Duration_or_Interval Arg1:T90 Arg2:T60	
R36	Used_for Arg1:T90 Arg2:T18	
R37	Has_Dose_or_Strength Arg1:T19 Arg2:T61	
R38	Has_Dose_or_Strength Arg1:T19 Arg2:T62	
R39	Combined_with Arg1:T19 Arg2:T20	
R40	Has_Dose_or_Strength Arg1:T20 Arg2:T63	
R41	Combined_with Arg1:T20 Arg2:T21	
R42	Has_Dose_or_Strength Arg1:T21 Arg2:T64	
R43	Before Arg1:T19 Arg2:T22	
R44	Used_for Arg1:T43 Arg2:T22	
R45	Has_Dose_or_Strength Arg1:T43 Arg2:T65	
R46	Combined_with Arg1:T43 Arg2:T23	
R47	Has_Dose_or_Strength Arg1:T23 Arg2:T84	
R48	Combined_with Arg1:T23 Arg2:T24	
R49	Has_Dose_or_Strength Arg1:T24 Arg2:T66	
R50	Has_Frequency Arg1:T24 Arg2:T85	
R51	Has_Frequency Arg1:T23 Arg2:T85	
R52	Has_Frequency Arg1:T43 Arg2:T85	
R53	Used_for Arg1:T43 Arg2:T25	
R54	Used_for Arg1:T23 Arg2:T25	
R55	Used_for Arg1:T24 Arg2:T25	
R56	Has_Route_or_Mode Arg1:T24 Arg2:T86	
R57	Has_Route_or_Mode Arg1:T23 Arg2:T86	
R58	Has_Route_or_Mode Arg1:T43 Arg2:T86	
R59	Has_Dose_or_Strength Arg1:T24 Arg2:T67	
R60	Has_Dose_or_Strength Arg1:T23 Arg2:T67	
R61	Has_Dose_or_Strength Arg1:T43 Arg2:T67	
T91	CONC 962 978	tiempo de cierre
#54	AnnotatorNotes T91	C4068527; PCA lockout time; Temporal Concept
R62	Has_Duration_or_Interval Arg1:T91 Arg2:T68	
R65	Overlap Arg1:T26 Arg2:T69	
R66	Overlap Arg1:T27 Arg2:T69	
T92	Quantifier_or_Qualifier 1057 1066	en reposo
#55	AnnotatorNotes T92	C0443144; At rest (qualifier value); Functional Concept
R67	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T92	
R68	Overlap Arg1:T26 Arg2:T81	
T93	CONC 1090 1112	escala verbal numérica
#56	AnnotatorNotes T93	C2735092; Pain severity verbal numeric scale; Intellectual Product
T94	Quantifier_or_Qualifier 1135 1141	máximo
#57	AnnotatorNotes T94	C0806909; Maximum; Quantitative Concept
R69	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T94	
R72	Used_for Arg1:T93 Arg2:T26	
R73	Overlap Arg1:T29 Arg2:T72	
R74	Overlap Arg1:T28 Arg2:T72	
R76	Overlap Arg1:T28 Arg2:T73	
R77	Overlap Arg1:T28 Arg2:T82	
R78	Overlap Arg1:T28 Arg2:T74	
R79	Overlap Arg1:T28 Arg2:T83	
T95	Quantifier_or_Qualifier 1398 1407	en reposo
#58	AnnotatorNotes T95	C0443144; At rest (qualifier value); Functional Concept
R80	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T95	
R81	Location_of Arg1:T47 Arg2:T31	
R82	Experiences Arg1:T76 Arg2:T33	
R83	Experiences Arg1:T76 Arg2:T34	
R84	Experiences Arg1:T76 Arg2:T32	
R85	Experiences Arg1:T76 Arg2:T31	
R86	Experiences Arg1:T76 Arg2:T30	
R87	Used_for Arg1:T77 Arg2:T35	
R88	Before Arg1:T35 Arg2:T48	
R89	Has_Route_or_Mode Arg1:T37 Arg2:T78	
R90	Before Arg1:T37 Arg2:T48	
R91	Causes Arg1:T35 Arg2:T36	
R92	Causes Arg1:T37 Arg2:T36	
R93	Has_Duration_or_Interval Arg1:T36 Arg2:T79	
R94	Overlap Arg1:T36 Arg2:T75	
R95	Overlap Arg1:T48 Arg2:T75	
R96	Has_Duration_or_Interval Arg1:T48 Arg2:T79	
R21	Overlap Arg1:T12 Arg2:T41	
A4	Experiencer T53 Patient
A5	Experiencer T71 Patient
A6	Experiencer T76 Patient
